Brazil halts trials of Chinese Covid-19 vaccine

Brazil’s health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an “adverse incident” involving a volunteer recipient, a blow for one of the most advanced vaccine candidates. The setback for CoronaVac, developed by Chinese pharmaceutical firm Sinovac Biotech, came on the same day US pharmaceutical giant Pfizer said its own vaccine candidate had shown 90% effectiveness, sending global markets soaring and raising hopes of an end to the pandemic. The Brazilian regulator, Anvisa, said in a statement it had “ruled to interrupt the clinical trial of the CoronaVac … (full story)More Champagne Sold in Washington DC Today Than Last 2 New Years Combined, Liquor Store Owners Say

Let's Have A Chat ​


please, upload jpg, jpeg, png or pdf files only